Table 3. Silencing of PKCδ prevents the genotoxic effects triggered by etoposide and BSO in SH-SY-5Y and in SK-N-BE-2C cells, respectively.
SH-SY-5Y | SK-N-BE-2C | ||||
standard (A.U.) | fpg (A.U.) | Standard (A.U.) | fpg (A.U.) | ||
CTR | NoT | 0.0006±0.0001 | 0.0004±0.0001 | 0.0008±0.0001 | 0.0006±0.0001 |
siPKCδ | 0.0006±0.0001 | 0.0007±0.0001 | 0.0009±0.0001 | 0.0008±0.0001 | |
ETOPO | NoT | 0.0004±0.0001 | 8.352±2.8754**,§§ | - | - |
siPKCδ | 0.0006±0.0001 | 0.0004±0.0001## | - | - | |
BSO | NoT | - | - | 11.325±2.184♦♦ | 13.215±1.969** |
siPKCδ | - | - | 0.0007±0.0001§§ | 0.0006±0.0001## |
NB cells, silenced for PKCδ, were treated with 0.07 µM etoposide (SH-SY-5Y) and 1 mM BSO (SK-N-BE-2C) for 24 h. DNA fragmentation (standard) and oxidation (fpg) were evaluated by comet test. The reported values derive from tail moment analyses.
**p<0.01 vs NoT CTR fpg;
p<0.01 vs NoT CTR standard;
p<0.01 vs NoT + ETOPO/BSO standard,
p<0.01 vs NoT ETOPO/BSO fpg.